Patent intelligence · US
US 10016474
Plant extract, compositions containing same, method of extraction and uses thereof
Plant extract, compositions containing same, method of extraction and uses thereof
Patent details — US 10016474
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jul 10, 2018
- Expiration
- Jul 5, 2038
- Applicant
- Botanic Century (Beijing) Co. Ltd.
- Claims
- 20
- CPC classes
- A61K, A61K36/605, A61K8/9789, A61K8/9794
Quick answer
US 10016474 (Plant extract, compositions containing same, method of extraction and uses thereof) is held by Botanic Century (Beijing) Co. Ltd.. Status: granted. Granted Jul 10, 2018. Expires Jul 5, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Botanic Century (Beijing) Co. Ltd.
- Grant date
- Expiration
- Claims
- 20
- CPC classes
- A61K, A61K36/605, A61K8/9789, A61K8/9794, A61P, A61P17/00
More from Botanic Century (Beijing) Co. Ltd.
Related pharmaceutical patents in our USPTO index.
-
US 12274710
Compound for regulating body weight imbalance, composition thereof and application thereof
granted -
US 12269888
Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
granted -
US 12194049
Composition for treating carbapenem antibiotic-resistant Acinetobacter baumannii infection
granted -
US 12084670
Regulating alkaloids
granted -
US 11883432
Chimeric antigen receptor system with adaptable receptor specificity
granted -
US 11865155
Plant extract obtained from Morus plant leaves which has an IC50 value to inhibit a-glucosidase I at a concentration of less than 90 uG/ml, compositions containing same, method of extraction and uses thereof
granted -
US 11667924
Increasing levels of nicotinic alkaloids in plants
granted -
US 11661459
Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
granted
Frequently asked questions
What is US patent 10016474?
US 10016474 (Plant extract, compositions containing same, method of extraction and uses thereof) is held by Botanic Century (Beijing) Co. Ltd.. Status: granted. Granted Jul 10, 2018. Expires Jul 5, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10016474?
Botanic Century (Beijing) Co. Ltd. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 39 pharmaceutical patents for this assignee.
When does US 10016474 expire?
Our index shows an expiration date of Jul 5, 2038 (12 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.